Trials / Sponsors / Provention Bio, a Sanofi Company
Provention Bio, a Sanofi Company
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | PRV-3279-2a Trial in Systemic Lupus Systemic Lupus Erythematosus | Phase 2 | 2022-01-20 |
| Active Not Recruiting | Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab (PROTECT Extension) Diabetes Mellitus, Type 1 | — | 2020-10-26 |
| Completed | PRV-015 in Gluten-free Diet Non-responsive Celiac Disease Celiac Disease | Phase 2 | 2020-08-24 |
| Completed | At-Risk for Type 1 Diabetes Extension Study (TN-10 Extension) Diabetes Mellitus, Type 1 | Phase 2 | 2020-02-26 |